Optimizing mifepristone levels in plasma serum of patients suffering from mental disorders treatable with glucocorticoid receptor antagonists

• 收藏
• 分享

专利权人:

发明人:

Joseph K. Belanoff

申请号：

US14065792

公开号：

US08921348B2

申请日:

2013.10.29

申请国别(地区):

US

年份:

2014

代理人:

摘要：

The present invention provides a method for optimizing levels of mifepristone in a patient suffering from a mental disorder amenable to treatment by mifepristone. The method comprises the steps of treating the patient with seven or more daily doses of mifepristone over a period of seven or more days testing the serum levels of the patient to determine whether the blood levels of mifepristone are greater than 1300 ng/mL and adjusting the daily dose of the patient to achieve mifepristone blood levels greater than 1300 ng/mL.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/